Results 11 to 20 of about 143,284 (315)

Is a Preoperative Gastrointestinal Endoscopy for Second Primary Cancer Detection in Head and Neck Cancer Necessary? Ten-year Registry Data

The Korean Journal of Gastroenterology, 2016
Background : /Aims: In head and neck squamous cell carcinoma, second primary gastrointestinal tumors are not uncommon. However, it is unclear whether a screening endoscopy is needed for detecting gastrointestinal neoplasm in patients with head and neck ...
Gyeong Mi Heo, Mi Hee Kim, Jin Hwan Kim, Young Soo Rho, Woon Geon Shin   +4 more
doaj   +1 more source

Human Papilloma Virus (HPV) Induced Head & Neck Squamous Cell Carcinoma: A Comprehensive Retrospect [PDF]

Journal of Clinical and Diagnostic Research, 2015
Head and Neck Squamous Cell Carcinoma accounts for the sixth most common malignancy occurring worldwide with tobacco and alcohol being the two well established risk factors.
Roquaiya Nishat, Shyam Sundar Behura, Sujatha Ramachandra, Harish Kumar, Alokenath Bandyopadhyay   +4 more
doaj   +1 more source

Squamous cell carcinoma of the head and neck in the elderly [PDF]

Reports of Practical Oncology & Radiotherapy, 2013
The incidence of head and neck squamous cell carcinoma (HNSCC) peaks between the fifth and seventh decades of life. With prolongation of life expectancy, however, the proportion of elderly HNSCC patients is also increasing, which makes HNSCC in this life period an important issue for healthcare providers.
Gugić, Jasenka, Strojan, Primož
openaire   +2 more sources

Immunotherapy for squamous cell carcinoma of the head and neck [PDF]

Japanese Journal of Clinical Oncology, 2020
Abstract Squamous cell carcinoma of the head and neck is characterized by an immunosuppressive environment and evades immune responses through multiple resistance mechanisms. A breakthrough in cancer immunotherapy employing immune checkpoint inhibitors has evolved into a number of clinical trials with antibodies against programmed cell ...
Tomoya Yokota, Akihiro Homma, Naomi Kiyota, Makoto Tahara, Nobuhiro Hanai, Takahiro Asakage, Kazuto Matsuura, Takenori Ogawa, Yuki Saito, Daisuke Sano, Takeshi Kodaira, Atsushi Motegi, Koichi Yasuda, Shunji Takahashi, Kaoru Tanaka, Takuma Onoe, Susumu Okano, Yoshinori Imamura, Yosuke Ariizumi, Ryuichi Hayashi   +19 more
openaire   +2 more sources

A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck [PDF]

, 2005
Objective: The purpose of this pilot study was to evaluate the feasibility and toxicity of concurrent chemotherapy with vinorelbine and mitomycin C in combination with accelerated radiotherapy (RT) in patients with locally advanced cancer of the head and
Wilkowski, R., Schalhorn, A., Dellian, M., Dühmke, Eckhart, Pachmann, S., Schymura, B.   +5 more
core   +1 more source

Exosomes in Head and Neck Squamous Cell Carcinoma [PDF]

Frontiers in Oncology, 2019
Exosomes are small membranous vesicles that contain proteins, lipids, genetic material, and metabolites with abundant information from parental cells. Exosomes carry and deliver bioactive contents that can reprogram the functions of recipient cells and modulate the tumor microenvironment to induce pathological events through cell-to-cell communication ...
Cheng Xiao, Fang Song, Yu Long Zheng, Jiong Lv, Qiang Feng Wang, Nong Xu   +5 more
openaire   +3 more sources

Postoperative irradiation for squamous cell carcinoma of head and neck: Retrospective comparison of accelerated radiochemotherapy and standard radiotherapy [PDF]

, 2000
Background: Comparison of accelerated radiochemotherapy (aRCT) and standard radiotherapy (sRT) in postoperative treatment after macroscopically complete resection of squamous cell cancers of head and neck.
Kiszel, Z., Busch, M., Kastenbauer, E., Panzer, Monika, Dühmke, Eckhart, Klaiber, R., Jund, R., Schaffer, Moshe, Winter, W.   +8 more
core   +1 more source

Hypoxia in Head and Neck Squamous Cell Carcinoma [PDF]

ISRN Otolaryngology, 2012
Hypoxia is a common feature in most of the solid tumors including head and neck squamous cell carcinoma (HNSCC). Hypoxia reflects the imbalance between oxygen consumption by the rapidly proliferating cancer cells and the insufficient oxygen delivery due to poor vascularization and blood supply.
John Zenghong Li, Wei Gao, Jimmy Yu-Wai Chan, Wai-Kuen Ho, Thian-Sze Wong   +4 more
openaire   +2 more sources

CD44s and CD44v6 Expression in Head and Neck Epithelia [PDF]

, 2008
Background: CD44 splice variants are long-known as being associated with cell transformation. Recently, the standard form of CD44 (CD44s) was shown to be part of the signature of cancer stem cells (CSCs) in colon, breast, and in head and neck squamous ...
Olivier Gires, Mack, B., Gires Olivier, Mack, Brigitte, Brigitte Mack, Gires, Olivier, Mack Brigitte, Gires, O.   +7 more
core   +1 more source

Cetuximab in squamous cell head and neck carcinomas

Annals of Oncology, 2007
The epidermal growth factor receptor (EGFR) antagonist, cetuximab, has recently been shown to enhance the effects of radiotherapy, and reports to date indicate that this effect occurs without any change in the pattern and severity of toxicity usually associated with head and neck radiation and/or chemotherapy (CT) administration.
GEBBIA, Vittorio, GIULIANI G, VALORI VM, AGUELI R, COLUCCI G, MAIELLO E.   +5 more
openaire   +3 more sources